1. Homogenous Magneto-Fluorescent Nanosensor for Tumor-Derived Exosome Isolation and Analysis
- Author
-
Jingyun Guo, Chunzuan Xu, Taixue An, Bo Situ, Bo Li, Junjie Feng, Jianlei Shen, Weilun Pan, Chunchen Liu, Ye Zhang, Lei Zheng, Tingting Luo, and Wancheng Zheng
- Subjects
Fluid Flow and Transfer Processes ,Chemistry ,Process Chemistry and Technology ,010401 analytical chemistry ,Liquid Biopsy ,Breast Neoplasms ,Bioengineering ,02 engineering and technology ,Integrated approach ,Tumor-Derived ,Exosomes ,021001 nanoscience & nanotechnology ,01 natural sciences ,Exosome ,Fluorescence ,Microvesicles ,0104 chemical sciences ,Magnetic isolation ,Nanosensor ,Biophysics ,Humans ,0210 nano-technology ,Instrumentation - Abstract
Tumor-derived exosomes carrying unique surface proteins have shown great promise as novel biomarkers for liquid biopsies. However, point-of-care analysis for tumor-derived exosomes in the blood with low-cost and easy processing is still challenging. Herein, we develop an integrated approach, homogenous magneto-fluorescent exosome (hMFEX) nanosensor, for rapid and on-site tumor-derived exosomes analysis. Tumor-derived exosomes are captured immunomagnetically, which further initiates the aptamer-triggered assembly of DNA three-way junctions in homogenous solution containing aggregation-induced emission luminogens and graphene oxide, resulting in an amplified fluorescence signal. By integrating magnetic isolation and enhanced fluorescence measurement, the hMFEX nanosensor detects tumor-derived exosomes in the dynamic range spanning 5 orders of magnitude with high specificity, and the limit of detection is 6.56 × 104 particles/μL. Analyzing tumor-derived exosomes in limited volume plasma from breast cancer patients demonstrates the excellent clinical diagnostic efficacy of the hMFEX nanosensor. This study provides new insights into the point-of-care testing of tumor-derived exosomes for cancer diagnostics.
- Published
- 2020
- Full Text
- View/download PDF